GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Beginning Cash Position

CG Oncology (CG Oncology) Beginning Cash Position : $8.27 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Beginning Cash Position?

CG Oncology's Beginning Cash Position for the quarter that ended in Mar. 2024 was $8.27 Mil.

CG Oncology's quarterly Beginning Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($10.27 Mil) but then declined from Dec. 2023 ($10.27 Mil) to Mar. 2024 ($8.27 Mil).

CG Oncology's annual Beginning Cash Position increased from Dec. 2021 ($51.91 Mil) to Dec. 2022 ($53.61 Mil) and increased from Dec. 2022 ($53.61 Mil) to Dec. 2023 ($88.14 Mil).

CG Oncology Beginning Cash Position Historical Data

The historical data trend for CG Oncology's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Beginning Cash Position Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
51.91 53.61 88.14

CG Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial 93.61 88.14 - 10.27 8.27

CG Oncology Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

CG Oncology Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of CG Oncology's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology (CG Oncology) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Beginning Cash Position
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

CG Oncology (CG Oncology) Headlines

From GuruFocus

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

By Marketwired • 04-24-2024